Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins

Prostate cancer is the second leading cause of cancer mortality in men in developed countries. Due to the heterogeneous nature of the disease, design of novel personalized treatments is required to achieve efficient therapeutic responses. We have recently identified phospholipase 2 group VII (PLA2G7...

Descripción completa

Detalles Bibliográficos
Autores principales: Vainio, Paula, Lehtinen, Laura, Mirtti, Tuomas, Hilvo, Mika, Seppänen-Laakso, Tuulikki, Virtanen, Johannes, Sankila, Anna, Nordling, Stig, Lundin, Johan, Rannikko, Antti, Orešič, Matej, Kallioniemi, Olli, Iljin, Kristiina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2011
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282076/
https://www.ncbi.nlm.nih.gov/pubmed/22202492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282076/
https://www.ncbi.nlm.nih.gov/pubmed/22202492

Ejemplares similares